Colan Totte.Co.,Ltd.

Colan Totte.Co.,Ltd.

TTSE:7792
1,477.00
JPY
+10.00
(+0.68%)
12.40BMarket Cap
Nov 06Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
340.26
360.92
453.54
522.37
602.12
658.69
762.98
- -
Basic EPS, GAAP
31.55
40.6
51.34
68.37
71.84
113.51
146.49
- -
Free Cash Flow per Basic Share
7.69
39.71
72.93
8.45
96.59
39.59
78.39
- -
Dividend per Share
- -
- -
- -
11.97
15.93
19.97
29.95
- -
Book Value per Share
65.26
103.03
251.06
306.45
362.17
453.69
568.39
610.59
Tangible Book Value per Share
53.58
92.24
243.46
301.19
357.97
449.87
565.1
607.79
Basic Weighted Avg Shares
9
8
8
9
9
9
9
9
Sales/Revenue/Turnover
2,926
2,887
3,715
4,664
5,407
5,945
6,918
- -
Operating Margin (%)
15.5
17.47
17.4
20.4
18.81
25.25
26.17
- -
Depreciation Expense
69
72
71
79
86
84
72
- -
Net Income, GAAP
271
325
421
610
645
1,024
1,328
- -
Effective Tax Rate (%)
36.68
32.72
31.92
35.34
36.66
30.9
27.32
- -
Profit Margin (%)
9.27
11.25
11.32
13.09
11.93
17.23
19.2
- -
Working Capital
273
484
1,672
2,054
2,374
2,587
3,299
3,328
LT Debt
567
440
270
156
- -
6
10
8
Total Equity
561
886
2,240
2,745
3,266
4,110
5,168
5,554
Return on Invested Capital (%)
- -
18.36
18.61
20.09
19.01
26.19
26.46
- -
Return on Capital (%)
- -
19
18.87
21.47
20.55
27.74
28.56
- -
Return on Common Equity (%)
- -
44.89
26.9
24.49
21.46
27.78
28.63
- -

Capital Structure

JPY

•

in mil. unless spec.
Mar'24
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
7
- -
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
8,270
13,393
12,399

Working Capital

JPY

•

in mil. unless spec.
Mar'24
Dec'26
Mar'26
Total Current Assets
3,912
- -
4,924
Cash, Cash Equivalents & STI
1,846
- -
2,115
Accounts Receivable, Net
494
- -
708
Inventories
1,281
- -
1,771
Total Current Liabilities
1,289
- -
1,596
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
49.18%
25.73%
Free Cash Flow
- -
217.98%
98.96%
Net Income, GAAP
- -
33.75%
29.65%
Sales/Revenue/Turnover
- -
19.29%
16.37%
Total Cash Common Dividend
- -
- -
50.65%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,744
1,145
- -
- -
5,945
2025
- -
- -
- -
- -
6,918
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
37.48
18.53
- -
- -
113.51
2025
- -
- -
- -
- -
146.49
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
19.97
2025
- -
- -
- -
- -
29.95
2026
- -
- -
- -
- -
- -

Company Description

CEO
Katsumi Komatsu
Full Time Employees
104
Sector
Electronic technology
Industry
Electronic equipment/Instruments
Address
Colantotte Building Osaka OS Japan 542-0081
IPO Date
Jul 8, 2021
Business
Colan Totte Co., Ltd. is a Japanese manufacturer specializing in medical devices and daily necessities, primarily focused on wearable magnetic therapy devices designed to improve blood circulation and relieve muscle stiffness. The company markets its flagship Colantotte brand, which includes a range of products such as magnetic therapy necklaces, bracelets, innerwear, room wear, and supportive clothing. These products feature the company's proprietary Alternating North-South Polarity Orientation (ANSPO™) technology that creates a broad-reaching magnetic field for therapeutic effects. Colan Totte sells its products through retail stores, wholesale channels, and e-commerce platforms both in Japan and internationally. Founded in 1997 and headquartered in Osaka, Japan, the company holds ISO 13485 certification for quality management and markets certain devices as Class I medical devices with CE marking for the European Union. In recent developments, Colan Totte has introduced an upgraded version of its power patch product, the NS Magneban 80 x 2, which features double the magnetic power, and launched new collaboration products with the Japanese brand doublet starting mid-2024. The company also expanded its product line with additions like the TAO Necklace α VEGA NEXT, which is the model with the highest magnetic flux density in its TAO Necklace series, released in late 2021. Colan Totte continues to enhance its product offerings targeting both general consumers and professional athletes, supporting healthy lifestyles through innovative magnetic therapy solutions. The company remains active in expanding its e-commerce footprint while maintaining its retail and wholesale operations domestically and abroad. Colan Totte operates in Japan with its headquarters located at 2-10-26 Minamisenba, Chuo-ku, Osaka, and maintains strategic banking relationships with major Japanese financial institutions including Mizuho Bank, MUFG Bank, and Sumitomo Mitsui Banking Corporation. The company’s recent focus has been on strengthening product innovation and strategic partnerships within the health and wellness segment, evidenced by new product launches and collaborations in the last 1-2 years. This comprehensive profile reflects Colan Totte’s position as a specialized medical device manufacturer delivering premium magnetic health gear primarily under the Colantotte brand to both domestic and global markets, headquartered in Osaka, Japan, since its establishment in 1997.